NNNN Anbio Biotechnology Class A Ordinary Shares

Healthcare

$33.01+1.51%ClosedMarket Cap: $1.45B

As of 2026-05-26

Valuation

P/E (TTM)

425.50

PEG

—

P/B

47.33

P/S

146.47

EV/EBITDA

219.16

DCF Value

$0.95

FCF Yield

0.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

87.1%

Operating Margin

66.5%

Net Margin

73.7%

ROE

23.0%

ROA

23.8%

ROIC

21.5%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 null	$4.7M	81.5%	$2.8M	$3.0M	$—	—
FY null	$9.8M	87.2%	$6.5M	$7.2M	$—	—
Q2 null	$5.0M	92.3%	$3.7M	$4.1M	$—	—
Q4 null	$2.5M	84.6%	$-1.7M	$-1.3M	$—	—
FY null	$8.2M	71.9%	$2.0M	$2.4M	$—	—
Q2 null	$6.3M	66.9%	$3.9M	$3.9M	$—	—
Q4 null	$4.0M	42.8%	$583.7K	$792.9K	$—	—
FY null	$6.7M	50.1%	$2.0M	$2.3M	$—	—
Q2 null	$3.3M	58.7%	$1.5M	$1.6M	$—	—
FY null	$23.5M	53.4%	$10.2M	$10.0M	$—	—
FY 2021	$4.4M	57.4%	$2.5M	$2.5M	$0.03	—